Scarica l'app Stockscreener
288.47
3.10%
8.68
Precedente Chiudi:
$279.79
Aprire:
$279.69
Volume 24 ore:
620.99K
Relative Volume:
1.41
Capitalizzazione di mercato:
$11.30B
Reddito:
$1.24B
Utile/perdita netta:
$42.23M
Rapporto P/E:
272.14
EPS:
1.06
Flusso di cassa netto:
$150.33M
1 W Prestazione:
+3.00%
1M Prestazione:
+15.85%
6M Prestazione:
+6.69%
1 anno Prestazione:
+19.95%
Intervallo 1D:
$279.69
$293.18
Intervallo di 1 settimana:
$276.01
$293.18
Portata 52W:
$221.26
$310.00
Penumbra Inc Stock (PEN) Company Profile
Nome
Penumbra Inc
Settore
Industria
Telefono
(510) 995-2486
Indirizzo
ONE PENUMBRA PLACE, ALAMEDA, CA
Confronta PEN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PEN
Penumbra Inc
|
288.47 | 10.96B | 1.24B | 42.23M | 150.33M | 1.06 |
|
ABT
Abbott Laboratories
|
128.11 | 215.57B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.88 | 143.20B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
368.27 | 137.86B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
101.20 | 127.43B | 34.76B | 4.79B | 5.21B | 3.7049 |
|
EW
Edwards Lifesciences Corp
|
85.13 | 48.80B | 5.88B | 1.34B | 799.60M | 2.3489 |
Penumbra Inc Stock (PEN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-18 | Iniziato | Wells Fargo | Underweight |
| 2025-10-08 | Aggiornamento | Needham | Hold → Buy |
| 2025-09-02 | Iniziato | Evercore ISI | Outperform |
| 2025-03-14 | Iniziato | BofA Securities | Buy |
| 2025-01-21 | Iniziato | UBS | Buy |
| 2024-12-17 | Iniziato | Oppenheimer | Outperform |
| 2024-12-11 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-09-18 | Iniziato | Stifel | Buy |
| 2024-09-03 | Iniziato | Leerink Partners | Outperform |
| 2024-07-31 | Downgrade | Citigroup | Buy → Neutral |
| 2024-07-31 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-02-23 | Downgrade | JP Morgan | Overweight → Neutral |
| 2023-09-06 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-03-29 | Downgrade | Needham | Buy → Hold |
| 2023-01-30 | Iniziato | Piper Sandler | Overweight |
| 2022-11-04 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-10-05 | Downgrade | Citigroup | Buy → Neutral |
| 2022-09-09 | Aggiornamento | Needham | Hold → Buy |
| 2022-07-18 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-04-19 | Iniziato | Deutsche Bank | Buy |
| 2022-03-08 | Iniziato | Needham | Hold |
| 2021-09-16 | Iniziato | Truist | Buy |
| 2021-06-04 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-12-16 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-10-07 | Ripresa | Canaccord Genuity | Buy |
| 2020-09-29 | Iniziato | BTIG Research | Buy |
| 2020-09-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2019-06-13 | Reiterato | BofA/Merrill | Buy |
| 2019-05-30 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2019-05-21 | Iniziato | William Blair | Outperform |
| 2018-10-29 | Ripresa | BofA/Merrill | Buy |
| 2018-10-08 | Iniziato | RBC Capital Mkts | Outperform |
| 2018-02-21 | Iniziato | William Blair | Outperform |
| 2018-01-02 | Downgrade | JP Morgan | Overweight → Neutral |
| 2015-11-30 | Reiterato | Canaccord Genuity | Buy |
| 2015-10-13 | Iniziato | Wells Fargo | Outperform |
Mostra tutto
Penumbra Inc Borsa (PEN) Ultime notizie
Penumbra, Corcept, Elanco, ResMed, and LeMaitre Stocks Trade Up, What You Need To Know - Finviz
[144] Penumbra Inc SEC Filing - Stock Titan
Shareholder Bose Family Holdings II LLC Files To Sell 30,000 Of Penumbra Inc [PEN] - TradingView
Can Penumbra Inc. stock reach $200 price targetGold Moves & Long-Term Growth Portfolio Plans - newser.com
What Wall Street predicts for Penumbra Inc. stock priceDollar Strength & Reliable Intraday Trade Alerts - newser.com
How supply shortages influence Penumbra Inc. stock2025 Price Targets & Scalable Portfolio Growth Ideas - newser.com
Why Penumbra Inc. (0P8) stock remains top ratedWeekly Market Summary & Momentum Based Trading Ideas - newser.com
Penumbra president Shruthi Narayan leads blood clot device makerBizwomen - The Business Journals
Is Penumbra Inc. stock trading at attractive multiplesEntry Point & Consistent Growth Equity Picks - newser.com
Why Penumbra Inc. stock fits value portfoliosEntry Point & Verified Technical Trade Signals - newser.com
Is Penumbra Inc. stock a top hedge fund pickJuly 2025 Closing Moves & Weekly Market Pulse Alerts - newser.com
Is Penumbra Inc. stock attractive for ETFsEarnings Summary Report & High Yield Equity Trading Tips - newser.com
Should I hold or sell Penumbra Inc. stock in 2025Quarterly Profit Report & Daily Growth Stock Tips - newser.com
Penumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference - Lelezard
Penumbra Inc. (PEN) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Why retail traders accumulate Penumbra Inc. (0P8) stockMarket Growth Summary & Verified Entry Point Signals - newser.com
Custom watchlist performance reports with Penumbra Inc.Dip Buying & Long-Term Safe Investment Ideas - newser.com
Does Penumbra Inc. stock trade at a discount to peersTrade Volume Summary & Technical Pattern Based Signals - newser.com
United States Interventional Neurology Devices Market 2025: - openPR.com
Why Penumbra (PEN) is a Top Momentum Stock for the Long-Term - sharewise.com
Is Penumbra Inc. stock attractive for retirement portfoliosJuly 2025 Institutional & Weekly Breakout Watchlists - newser.com
[Form 4] Penumbra Inc Insider Trading Activity - Stock Titan
CFO Yuen Surrenders 691 Of Penumbra Inc [PEN] - TradingView
Penumbra Inc Azioni (PEN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.84%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):